Insulin

Tests of a new insulin drug in pigs with diabetes found it was twice as fast-acting as traditional insulin.

Long-acting insulin Lantus will be discontinued from the Pharmaceutical Benefits Scheme (PBS) as of June 30, 2020.

All your questions on insulin answered

After a month of devotion and restraint it is easy to go overboard with the delicious treats. Eating slowly, focusing on the feel, taste and sensation of chewing each mouthful will help set you for the day.

Researchers have found a way to combine insulin with amylin, to create an injection that could help people living with diabetes control their blood glucose levels.

Research into type 2 diabetes, glucagon, insulin and management of blood glucose levels

A Canadian study has found that a novel dual-hormone closed loop system improves glucose control for type 1 diabetes

Researchers have found that children with type 1 diabetes need to eat more vegetables and less snacks.

Australia's leading diabetes groups and the Pharmacy Guild are working together to ensure the availability of essential medicines

COVID-19 (coronavirus) planning for people living with diabetes

A new Canadian study has found that a novel dual-hormone closed loop system improves glucose control when compared with using rapid insulin-alone.

A new technique to convert human stem cells into insulin-producing cells could hold huge promise for the future treatment of diabetes.

Researcher have found that changes in DNA sequence can trigger the chromosomes to misfold in a way that puts one at a heightened risk for type 1 diabetes.

Researchers in the US have developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people living with diabetes and deliver the necessary insulin dosage.

An international group of scientists have now conducted a detailed examination in living cells of the Glucagon-like peptide-1 receptors (GLP1R), which are found on insulin-producing beta cells of the pancreas and neurons in the brainreceptor.

Our program 'Living with Insulin' is a great program for people already living with insulin, for both type 1 and type 2 diabetes.

When camping in the summer heat, it's a good idea to consider medication storage for diabetes management, and food safety

Don't let diabetes hold you back from enjoying your holiday or business travels. Use this checklist to get prepared. Travelling overseas with different time zones, climates, foods and hygiene standards can be successfully managed with pre-trip advice from your doctor or diabetes educator.

In a promising discovery that could improve the delivery of insulin and diabetes therapy, scientists have developed a non-fibrillating form of human insulin.

It's the start of a new year and a perfect time to review your medications.

In a new study from researchers from UCLA have discovered the process which may explain how type 2 diabetes develops.

 Travel provides adventure and an escape from daily life. But to confidently enjoy your travels it's critical to be adequately insured.

Do you ever hear the questions "should you be eating that?". We help with a few responses to that annoying question for people living with diabetes.

For people who live with type 2 diabetes, exercise is a foundation of good health.

Fiasp, a fast-acting insulin, has featured in many blogs and forums after it was added this month to Australia's Pharmaceutical Benefits Scheme (PBS).

A new smart insulin has been developed which could help people prevent hypoglycaemia, researchers have said. Currently known as i-insulin, a research team from the University of California (UCLA) in Los Angeles have added an extra molecule to the hormone which they say can prevent low blood glucose levels.

There are more Australians living with type 2 diabetes using insulin than people with type 1. Find out more about how Flash Glucose Monitoring technology can help people on insulin to live with greater ease than our grandparents could ever have imagined.

Researchers have identified an elusive trigger of type 1 diabetes.

A new campaign 'The Diabetes Low Down' has been launched to raise awareness of how 'hypos' affect people living with type 1 and type 2 diabetes who take insulin.

Researchers in Norway recently made what they believe to be an exciting discovery that they believe could change the way we manage diabetes and it's all to do with our bodies' own cells.

The AFDR has entered into an arrangement with Israeli company Kadimastem to explore overcoming the need for insulin administration in people with type 1 diabetes.